Trevena Stock Trading Halted; FDA Advisory Committee to Review Oliceridine for the Treatment of Moderate to Severe Acute Pain Oct 11, 2018 7:00am EDT
Trevena announces completion of leadership transition and appointment of new director Oct 01, 2018 7:00am EDT
Trevena to Present Oliceridine, a Next Generation IV Opioid for the Management of Moderate to Severe Acute Pain, at FDA Advisory Committee Meeting on October 11, 2018 Sep 10, 2018 4:01pm EDT
Trevena to Present at the 20th Annual Rodman & Renshaw Global Investment Conference Aug 30, 2018 4:30pm EDT
Trevena announces successful completion of Phase 1 study of TRV250 for acute migraine Jun 28, 2018 4:01pm EDT
Trevena Expands Commercial and Medical Affairs Leadership Teams with Key Hires Jun 11, 2018 4:01pm EDT
Trevena announces presentations at the American Society of Colon and Rectal Surgeons 2018 Annual Scientific Meeting May 22, 2018 7:00am EDT
